Novartis CEO Vasant Narasimhan says AI could cut drug development from 12 years to eight and lift success rates. Here's how it would work.
Coverage spectrum
Read at your length
Novartis CEO Vasant Narasimhan says AI could cut drug development from 12 years to eight and lift success rates. Here's how it would work.
AI's integration in pharma could revolutionize drug development, enhancing efficiency and success rates, but regulatory and policy challenges remain. The post Novartis CEO says AI could cut drug development time to eight years appeared first on Crypto Briefing. Novartis CEO Vasant Narasimhan says artificial intelligence could help cut drug-development times from 12 years to eight and significantly improve the odds of bringing new medicines to market.
Crypto Briefing reported the story as "Novartis CEO says AI could cut drug development time to eight years."
2 sources have covered this story, including Crypto Briefing and Bloomberg. The earliest reporting in the cluster landed about 6 hours ago.
How each side is reporting it
How the left is reporting it
How the wires + center are reporting it
How the right is reporting it
How it spread
Left 0Center 2Right 0No left or right outlets yet.
Time since the first report
Who carried it, in order
- FirstBloombergNov 20, 9:23 AM ET · United StatesCenter
- +13mCrypto BriefingNov 20, 9:36 AM ET · United StatesCenter
Claim ledger
[01] VerifiedCore event reported by 2 independent outlets across the spectrum.
[02] DisputedKey facts present in mainstream desks; corroboration thin from wires.